CG Oncology CGON Ratios (2023-2026)

NASDAQ CGON
$70.52 +0.91 (+1.31%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

CG Oncology Quarterly Ratios

Periods 14 quarters
Latest Jun 2026

CG Oncology reported a gross margin of -239.24% and a net margin of -6,836.65% for the quarter ended Jun 2026. These financial ratios cover 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin 100.00%100.00%100.00%5.34%-32.21%-173.50%-239.24%
EBT Margin -4,471.65%-130,666.67%-1,655,100.00%-3,199.43%-17,036.04%-47,448.84%-6,974.56%-66,263.46%-2,623.53%-1,776.74%-5,549.49%-6,834.23%
EBIT Margin -5,010.82%-156,033.33%-1,935,500.00%-4,247.45%-23,290.99%-65,802.33%-8,344.08%-81,161.54%-3,068.97%-2,097.33%-6,130.10%-7,467.68%
EBITDA Margin -5,008.76%-155,977.78%-1,935,100.00%-4,246.69%-23,284.68%-65,753.49%-8,344.08%-81,115.38%-3,044.00%-2,060.77%-6,052.45%-7,394.21%
Operating Margin -5,010.82%-156,033.33%-1,935,500.00%-4,247.45%-23,290.99%-65,802.33%-8,344.08%-81,161.54%-3,068.97%-2,097.33%-6,130.10%-7,467.68%
Net Margin -6,392.27%-194,600.00%-2,249,000.00%-3,200.76%-17,028.83%-47,453.49%-6,973.25%-66,253.85%-2,629.53%-1,778.64%-5,558.82%-6,836.65%
FCF Margin -4,116.49%-136,244.44%-1,464,500.00%-4,919.47%-14,535.14%-37,018.60%-4,576.97%-56,332.69%-2,340.40%-1,559.99%-5,285.96%-4,055.75%
Efficiency
Inventory AverageInventory Avg. 1.53M1.53M1.25M
Assets AverageAssets Avg. 389.20M571.72M558.40M653.63M741.49M714.81M715.68M760.75M963.43M1,110.46M
Equity AverageEquity Avg. -91.75M-102.49M-115.34M222.92M560.65M544.56M635.07M719.07M687.56M679.00M720.12M922.19M1,060.45M
Invested CapitalInvested Cap. 733.38M690.64M755.60M1,094.78M1,032.12M
Asset Utilization RatioAsset Util. 0.000.000.000.000.000.000.000.010.010.01
Leverage & Solvency
Debt Ratio 0.000.000.000.00
Valuation
Price to SalesP/S 0.00M0.00M0.00M0.00M0.00M0.00M0.00M829.260.00M0.00M
Price to BookP/B 3.633.814.752.442.652.964.594.455.466.10
Enterprise Value 1,499.64M1,551.57M2,007.49M1,050.41M1,178.23M1,320.98M2,472.75M2,608.06M4,880.12M5,245.89M
Market Capitalization 2,066.14M2,104.45M2,548.20M1,792.41M1,866.66M1,982.03M3,153.02M3,350.21M5,956.37M6,274.17M
Return Ratios
Return on Sales [ROS]ROS -5,010.82%-156,033.33%-1,935,500.00%-4,247.45%-23,290.99%-65,802.33%-8,344.08%-81,161.54%-28,546.10%-3,068.97%-2,097.33%-6,130.10%-7,467.68%
Return on Capital Employed [ROCE]ROCE -17.98%-14.60%-17.68%-18.14%-18.70%-22.98%-26.29%-26.14%-23.16%-23.76%
Return on Assets [ROA]ROA -14.59%-11.22%-13.04%-13.47%-14.24%-17.92%-21.15%-21.14%-19.36%-20.18%
Return on Equity [ROE]ROE -25.48%-11.44%-13.37%-13.86%-14.68%-18.63%-22.30%-22.34%-20.22%-21.14%

CG Oncology Ratios API

Pull CG Oncology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CGON&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY